Close

BMO Capital Upgrades Fate Therapeutics (FATE) to Outperform Jul 11, 2022 07:14AM
Fate Therapeutics (FATE) PT Raised to $88 at BMO Capital Jan 25, 2021 07:29AM
Fate Therapeutics (FATE) PT Raised to $43 at BMO Capital Nov 6, 2020 07:19AM
Fate Therapeutics (FATE) PT Raised to $27 at BMO Capital Aug 7, 2019 07:47AM
Fate Therapeutics (FATE) PT Raised to $20 at BMO Capital; 'Enthusiasm for Cell Therapies Probably Justified' Mar 6, 2018 01:13AM


Nov 2, 2017 07:58AM Fate Therapeutics (FATE) ASH Abstracts 'Underappreciated' - BMO
Mar 17, 2017 06:11AM Fate Therapeutics (FATE) PT Raised to $7 at BMO Capital
Dec 5, 2016 06:27AM BMO Positive on Fate Therapeutics (FATE) Following Adaptive NK Cell Therapy-Focused ASH Dinner
Jun 20, 2016 01:50PM Fate Therapeutics (FATE) Fast Track Provides Greater FDA Access - BMO Capital
Apr 11, 2016 04:35PM BMO Capital Starts Fate Therapeutics (FATE) at Outperform
Jun 16, 2015 06:40AM Fate Therapeutics (FATE) Bullish Stance Reiterated at BMO Capital Following Meetings
Jun 8, 2015 07:54AM Fate Therapeutics' (FATE) Boston Children Hospital Deal Broadens ProHema Franchise Into Autoimmune Disease, BMO Capital Says
May 27, 2015 04:01PM Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
May 27, 2015 04:01PM Fate Therapeutics Announces Completion of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
May 21, 2015 06:16AM Fate Therapeutics (FATE) Prices 6M Common Offering at $5/Share
May 20, 2015 10:38PM Fate Therapeutics Announces Pricing of Public Offering of Common Stock
May 18, 2015 04:09PM Fate Therapeutics (FATE) Announces 6M Common Offering
May 18, 2015 04:08PM Fate Therapeutics Announces Proposed Public Offering of Common Stock
May 18, 2015 04:08PM Fate Therapeutics Announces Proposed Public Offering of Common Stock
May 6, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 5/6: (DIS) (FATE) (OCLR) (CRAY)
May 6, 2015 11:14AM BMO Capital Says Juno Deal 'Validates' Fate Therapeutics (FATE) Stem Cell Modulation Platform
Mar 20, 2014 10:43AM Fate Therapeutics (FATE) Target Price Lifted at BMO Capital
Oct 28, 2013 07:03AM BMO Capital Starts Fate Therapeutics (FATE) at Outperform
Oct 1, 2013 11:01AM Fate Therapeutics (FATE) IPO Opens Higher
Oct 1, 2013 10:52AM Fate Therapeutics (FATE) IPO Set to Open on NASDAQ
Aug 14, 2013 08:25AM Fate Therapeutics (FATE) Files $69M IPO